NO984547L - New oxazolidine derivatives, processes for their preparation, and drugs containing these compounds - Google Patents

New oxazolidine derivatives, processes for their preparation, and drugs containing these compounds

Info

Publication number
NO984547L
NO984547L NO984547A NO984547A NO984547L NO 984547 L NO984547 L NO 984547L NO 984547 A NO984547 A NO 984547A NO 984547 A NO984547 A NO 984547A NO 984547 L NO984547 L NO 984547L
Authority
NO
Norway
Prior art keywords
compounds
preparation
processes
drugs containing
oxazolidine derivatives
Prior art date
Application number
NO984547A
Other languages
Norwegian (no)
Other versions
NO984547D0 (en
Inventor
Christos Tsaklakidis
Liesel Doerge
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19612827A external-priority patent/DE19612827A1/en
Priority claimed from DE1996154479 external-priority patent/DE19654479A1/en
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO984547D0 publication Critical patent/NO984547D0/en
Publication of NO984547L publication Critical patent/NO984547L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Nye oksazolidinderivater, en fremgangsmåte for fremstilling av slike samt medikamenter inneholdende forbind- elsene. Forbindelsene er representert med den generelle formel (I) hvori symbolene har betydningene angitt i kravene.New oxazolidine derivatives, a process for the preparation of such as well as drugs containing the compounds. The compounds are represented by the general formula (I) wherein the symbols have the meanings set forth in the claims.

NO984547A 1996-03-30 1998-09-29 New oxazolidine derivatives, processes for their preparation, and drugs containing these compounds NO984547L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19612827A DE19612827A1 (en) 1996-03-30 1996-03-30 New (pyridyl-piperidinyl)-(carboxy-cycloalkyl)cycloalkano:oxazolidinone
DE1996154479 DE19654479A1 (en) 1996-12-27 1996-12-27 Oxazolidine derivs. to inhibit blood platelet aggregation,
PCT/EP1997/001542 WO1997036899A1 (en) 1996-03-30 1997-03-26 Novel oxazolidine derivatives, process for their production and medicaments containing them

Publications (2)

Publication Number Publication Date
NO984547D0 NO984547D0 (en) 1998-09-29
NO984547L true NO984547L (en) 1998-11-30

Family

ID=26024325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984547A NO984547L (en) 1996-03-30 1998-09-29 New oxazolidine derivatives, processes for their preparation, and drugs containing these compounds

Country Status (16)

Country Link
EP (1) EP0891359A1 (en)
JP (1) JP2000510445A (en)
KR (1) KR20000005117A (en)
CN (1) CN1219933A (en)
AR (1) AR006452A1 (en)
AU (1) AU722747B2 (en)
BR (1) BR9708475A (en)
CA (1) CA2250250A1 (en)
CZ (1) CZ305198A3 (en)
HU (1) HUP9901741A3 (en)
IL (1) IL126390A0 (en)
NO (1) NO984547L (en)
NZ (1) NZ332245A (en)
PL (1) PL329053A1 (en)
TR (1) TR199801961T2 (en)
WO (1) WO1997036899A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999032486A1 (en) * 1997-12-23 1999-07-01 Alcon Laboratories, Inc. Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
WO2002074762A1 (en) * 2001-03-15 2002-09-26 Takeda Chemical Industries, Ltd. Process for producing sulfone derivative
SI1598340T1 (en) * 2001-04-18 2009-08-31 Euro Celtique Sa 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
AU2003235895A1 (en) * 2002-05-09 2003-11-11 Mochida Pharmaceutical Co., Ltd. Process for producing 1-(4-pyridyl)-4-piperidone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9122016D0 (en) * 1991-10-16 1991-11-27 Glaxo Group Ltd Chemical compounds
AU2915892A (en) * 1991-11-14 1993-06-15 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
AU3351293A (en) * 1992-01-21 1993-08-03 Glaxo Group Limited Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
DK0623615T3 (en) * 1993-05-01 1999-12-13 Merck Patent Gmbh Adhesion receptor antagonists
DE19524765A1 (en) * 1995-07-07 1997-01-09 Boehringer Mannheim Gmbh New oxazolidinone derivatives, processes for their preparation and medicaments containing these compounds

Also Published As

Publication number Publication date
EP0891359A1 (en) 1999-01-20
AU722747B2 (en) 2000-08-10
HUP9901741A2 (en) 1999-09-28
CZ305198A3 (en) 1999-02-17
TR199801961T2 (en) 1999-01-18
PL329053A1 (en) 1999-03-01
CN1219933A (en) 1999-06-16
KR20000005117A (en) 2000-01-25
BR9708475A (en) 1999-04-13
AU2505697A (en) 1997-10-22
WO1997036899A1 (en) 1997-10-09
AR006452A1 (en) 1999-08-25
CA2250250A1 (en) 1997-10-09
JP2000510445A (en) 2000-08-15
HUP9901741A3 (en) 2000-03-28
NO984547D0 (en) 1998-09-29
NZ332245A (en) 2000-03-27
IL126390A0 (en) 1999-05-09

Similar Documents

Publication Publication Date Title
NO20045369L (en) New, substituted sulfamate anticonvulsant derivatives
NO971471L (en) New carboxamides with fungicidal activity
MY107740A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
NO970175L (en) Pyrido-canceled thienyl and furanyl oxazolidinones
NO992821L (en) Ketobenzamides as Calpain Inhibitors
NO930517L (en) BENZIMIDAZOLYL DERIVATIVES, PHARMACEUTICALS CONTAINING THESE, AND PROCEDURES FOR THEIR PREPARATION
NO20054329L (en) Adamantan derivatives, processes for their preparation, and pharmaceutical compositions which include them
NO970512L (en) Novel heteroaryl-oxazolidinones
NO20051695L (en) Novel spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
NO964700L (en) Novel amino acid derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
NO20062202L (en) Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromene-6-yl derivatives, processes and intermediates for their preparation, and drugs containing these compounds
DE69709938T2 (en) N-BENZYLPIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES
NO20021859D0 (en) New digosaccharides, their preparation as well as pharmaceutical preparations
WO2001010894A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
NO20053809L (en) Diarylmethylindenepiperidine derivatives, process for their preparation, and use thereof
DE50011034D1 (en) N-SUBSTITUTED 4-AMINOOPTERIDINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS
DE69229339T2 (en) CRYSTALLINE TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PRODUCTION AND USE
NO971625L (en) Novel peptides with immunomodulatory effects
DK1194415T3 (en) New piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing them and a process for their preparation
YU40002A (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
DK534381A (en) PROCEDURE FOR THE PREPARATION OF 2-OXOAZETIME DERIVATIVES
DE69427517T2 (en) Tetracyclic condensed heterocyclic compounds for the treatment of senile dementia
NO984547L (en) New oxazolidine derivatives, processes for their preparation, and drugs containing these compounds
ATE35812T1 (en) GAMMA BUTYROLACTONE DERIVATIVES, PROCESSES FOR MANUFACTURE THE SAME AND IMMUNOMODULATING PREPARATIONS CONTAINING THE SAME ACTIVE INGREDIENTS.
HU910784D0 (en) Process for producing new urea derivatives as well as pharmaceutical preparatives containing these compounds as active substance

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application